ACP-103

pimavanserin · ACADIA Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ACP-103, covering 2007-03-22 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: ACP-103 to Treat Parkinson's Disease [Phase 2]